DMIIU NASDAQ
Drugs Made In America Acquisition II Corp. Unit
1W: +0.6%
1M: +0.9%
3M: +1.3%
YTD: +2.9%
1Y: +2.8%
$10.29
Last traded 2026-10-27 — delisted
Credit Risk of going bust: not rated, financial company (lending is its business) Bonds: none of note held by US funds details ▾
Not rated: lending and leverage are a financial company's business, which the model misreads.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
1 relationships1
As Filer
counterparties named
0
As Counterparty
mentioned by others
1
Rel. Types
2026-04-03
Earliest Filing
2026-04-03
Latest Filing
investor: 1
Counterparties (Filed by DMIIU)
1 relationshipsCompanies named in DMIIU's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Alpha Multi Family Office | — | investor | Issued convertible notes and entered into investment and sponsor transition agreement for financing. | 2026-04-03 | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR